VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $17,033,000 | -70.2% | 732,908 | -73.4% | 0.05% | -72.6% |
Q4 2017 | $57,221,000 | +364.1% | 2,753,652 | +286.4% | 0.19% | +313.3% |
Q2 2017 | $12,329,000 | +57.6% | 712,674 | +32.3% | 0.04% | +50.0% |
Q4 2016 | $7,823,000 | +121.2% | 538,803 | +206.8% | 0.03% | +100.0% |
Q2 2016 | $3,536,000 | +1132.1% | 175,594 | +1507.1% | 0.02% | +1400.0% |
Q1 2016 | $287,000 | -98.4% | 10,926 | -89.5% | 0.00% | -98.9% |
Q3 2015 | $18,496,000 | -71.1% | 103,660 | -64.1% | 0.10% | -68.2% |
Q2 2015 | $64,076,000 | -34.2% | 288,598 | -41.2% | 0.30% | -37.7% |
Q1 2015 | $97,415,000 | +643.3% | 490,657 | +435.7% | 0.48% | +557.5% |
Q4 2014 | $13,106,000 | -86.7% | 91,584 | -88.3% | 0.07% | -83.6% |
Q2 2014 | $98,680,000 | +121.5% | 782,433 | +131.5% | 0.44% | +86.2% |
Q1 2014 | $44,552,000 | +5597.2% | 337,951 | +4973.6% | 0.24% | +5875.0% |
Q4 2013 | $782,000 | -97.0% | 6,661 | -97.4% | 0.00% | -97.6% |
Q3 2013 | $26,267,000 | – | 251,766 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |